- Home
- STC vs VRDN Comparison
STC vs VRDN Comparison
Compare STC & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STC | VRDN |
|---|---|---|
| Founded | 1893 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | STC | VRDN |
|---|---|---|
| Price | $65.44 | $16.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 14 |
| Target Price | ★ $81.00 | $35.46 |
| AVG Volume (30 Days) | 136.8K | ★ 1.5M |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.00% | N/A |
| EPS Growth | ★ 55.17 | N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | ★ $2,921,636,000.00 | $5,706,000.00 |
| Revenue This Year | $13.62 | $13.73 |
| Revenue Next Year | $7.13 | $279.00 |
| P/E Ratio | $120.16 | ★ N/A |
| Revenue Growth | ★ 17.32 | N/A |
| 52 Week Low | $56.39 | $13.18 |
| 52 Week High | $78.61 | $34.29 |
Technical Indicators
Market Signals| Indicator | STC | VRDN |
|---|---|---|
| Relative Strength Index (RSI) | 46.55 | 50.25 |
| Support Level | $62.45 | $15.58 |
| Resistance Level | $66.92 | $18.05 |
| Average True Range (ATR) | 1.65 | 0.76 |
| MACD | 0.08 | 0.01 |
| Stochastic Oscillator | 51.83 | 49.06 |
Price Performance
Historical ComparisonAbout STC Stewart Information Services Corporation
Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments: Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.